
TY  - JOUR
TI  - Ramazzini Prize
JO  - Internal Medicine Journal
VL  - 39
IS  - s3
SN  - 1444-0903
UR  - https://doi.org/10.1111/j.1445-5994.2009.02010.x
DO  - doi:10.1111/j.1445-5994.2009.02010.x
SP  - A94
EP  - A96
PY  - 2009
ER  - 

TY  - JOUR
TI  - Index
JO  - FEBS Letters
VL  - 298
IS  - S1
SN  - 0014-5793
UR  - https://doi.org/10.1016/0014-5793(92)80006-3
DO  - doi:10.1016/0014-5793(92)80006-3
SP  - 1
EP  - 202
PY  - 1992
ER  - 

TY  - JOUR
TI  - RACP Trainee Research Awards (Adult Medicine)
JO  - Internal Medicine Journal
VL  - 39
IS  - s3
SN  - 1444-0903
UR  - https://doi.org/10.1111/j.1445-5994.2009.02005.x
DO  - doi:10.1111/j.1445-5994.2009.02005.x
SP  - A83
EP  - A84
PY  - 2009
ER  - 

TY  - JOUR
AU  - Thomas, Alison S.
AU  - Mehta, Atul
AU  - Hughes, Derralynn A.
TI  - Gaucher disease: haematological presentations and complications
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 165
IS  - 4
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.12804
DO  - doi:10.1111/bjh.12804
SP  - 427
EP  - 440
KW  - Gaucher disease
KW  - glycosphingolipid
KW  - splenomegaly
KW  - thrombocytopenia
KW  - myeloma
PY  - 2014
AB  - Summary Gaucher disease (GD) is an autosomal recessive lysosomal storage disease, caused by deficiency of the enzyme glucocerebrosidase, required for the degradation of glycosphingolipids. Clinical manifestations include hepatosplenomegaly, thrombocytopenia, bone disease and a bleeding diathesis, frequently resulting in presentation to haematologists. Historically managed by splenectomy, transfusions and orthopaedic surgery, the development of specific therapy in the form of intravenous enzyme replacement therapy in the 1990s has resulted in dramatic improvements in haematological and visceral disease. Recognition of complications, including multiple myeloma and Parkinson disease, has challenged the traditional macrophage-centric view of the pathophysiology of this disorder. The pathways by which enzyme deficiency results in the clinical manifestations of this disorder are poorly understood; altered inflammatory cytokine profiles, bioactive sphingolipid derivatives and alterations in the bone marrow microenvironment have been implicated. Further elucidating these pathways will serve to advance our understanding not only of GD, but of associated disorders.
ER  - 

TY  - JOUR
TI  - AMERICAN TRANSPLANT CONGRESS 2012 ABSTRACTS
JO  - American Journal of Transplantation
VL  - 12
IS  - s3
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2012.04112.x
DO  - doi:10.1111/j.1600-6143.2012.04112.x
SP  - 27
EP  - 542
PY  - 2012
ER  - 

TY  - JOUR
TI  - American Society for Laser Medicine and Surgery Abstracts
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 48
IS  - S27
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.22485
DO  - doi:10.1002/lsm.22485
SP  - 1
EP  - 92
PY  - 2016
ER  - 

AU  - Ameduri, Rebecca
AU  - Canter, Charles E.
C7  - pp. 1001-1020
TI  - Pediatric Heart Transplantation
SN  - 9781444335897
UR  - https://doi.org/10.1002/9781444398786.ch70
DO  - doi:10.1002/9781444398786.ch70
SP  - 1001-1020
KW  - pediatric heart transplantation
KW  - pediatric heart transplants, infants <1 year of age
KW  - mortality associated with heart transplantation
KW  - AHA guidelines, heart transplantation for pediatric heart disease
KW  - basic evaluation protocol, for pediatric heart transplantation
KW  - UNOS criteria, pediatric heart transplant candidates in the US
KW  - goal of immunosuppression, preventing donor heart rejection
KW  - endomyocardial biopsy, “gold standard” for cellular rejection
KW  - transplant cardiac allograft vasculopathy
KW  - heart retransplantation
PY  - 2016
AB  - Summary This chapter contains sections titled: Outcomes Indications/evaluation Listing process/donor selection Immunosuppression after transplantation Rejection Infection Transplant cardiac allograft vasculopathy Other medical morbidities Heart retransplantation Heart?lung and lung transplantation and pediatric cardiovascular disease References
ER  - 

TY  - JOUR
TI  - 10th Annual meeting of French Society of Pharmacology, 73rd Annual meeting of Society of Physiology, 27th pharmacovigilance meeting, 54th APNET Seminar and 4th CHU CIC meeting (Corum Montpellier 10-12 April 2006)
JO  - Fundamental & Clinical Pharmacology
VL  - 20
IS  - 2
SN  - 9781444335897
UR  - https://doi.org/10.1111/j.1472-8206.2006.00409.x
DO  - doi:10.1111/j.1472-8206.2006.00409.x
SP  - 145
EP  - 234
PY  - 2006
ER  - 

TY  - JOUR
TI  - IMSANZ Free Papers
JO  - Internal Medicine Journal
VL  - 39
IS  - s3
SN  - 9781444335897
UR  - https://doi.org/10.1111/j.1445-5994.2009.02009.x
DO  - doi:10.1111/j.1445-5994.2009.02009.x
SP  - A91
EP  - A94
PY  - 2009
ER  - 

TY  - JOUR
TI  - AFPHM Free Papers
JO  - Internal Medicine Journal
VL  - 39
IS  - s3
SN  - 9781444335897
UR  - https://doi.org/10.1111/j.1445-5994.2009.02013.x
DO  - doi:10.1111/j.1445-5994.2009.02013.x
SP  - A99
EP  - A101
PY  - 2009
ER  - 

TY  - JOUR
TI  - Sunday: ISBT Educational Programme E1: Safe Blood
JO  - Vox Sanguinis
VL  - 95
IS  - s1
SN  - 9781444335897
UR  - https://doi.org/10.1111/j.1423-0410.2008.01055.x
DO  - doi:10.1111/j.1423-0410.2008.01055.x
SP  - 3
EP  - 73
PY  - 2008
ER  - 

TY  - JOUR
TI  - AES Proceedings
JO  - Epilepsia
VL  - 40
IS  - s7
SN  - 9781444335897
UR  - https://doi.org/10.1111/j.1528-1157.1999.tb01726.x
DO  - doi:10.1111/j.1528-1157.1999.tb01726.x
SP  - 1
EP  - 251
PY  - 1999
ER  - 

TY  - JOUR
AU  - Mearns, Alan J.
AU  - Reish, Donald J.
AU  - Oshida, Philip S.
AU  - Morrison, Ann Michelle
AU  - Rempel-Hester, Mary Ann
AU  - Arthur, Courtney
AU  - Rutherford, Nicolle
AU  - Pryor, Rachel
TI  - Effects of Pollution on Marine Organisms
JO  - Water Environment Research
JA  - Water Environment Research
VL  - 88
IS  - 10
SN  - 9781444335897
UR  - https://doi.org/10.2175/106143016X14696400495695
DO  - doi:10.2175/106143016X14696400495695
SP  - 1693
EP  - 1807
KW  - TISSUE RESIDUES
KW  - TOXICITY
KW  - BIOACCUMULATION
KW  - BIOMAGNIFICATION
KW  - BIOMARKERS
KW  - SEDIMENT
KW  - QUALITY
KW  - ECOLOGICAL RISK ASSESSMENT
KW  - ENDOCRINE DISRUPTERS
KW  - METALS
KW  - NANO PARTICLES
KW  - POPS
KW  - PCBS
KW  - PAHS
KW  - PBDES
KW  - RADIONUCLIDES
KW  - PHARMACEUTICALS
KW  - PERSONAL CARE PRODUCTS
KW  - TRACE METALS
KW  - PESTICIDES
KW  - BIOMARKERS
KW  - MARINE BIOCIDES
KW  - OIL
KW  - SPILLS
KW  - DISPERSANTS
KW  - FIELD SURVEY METHODS
KW  - SEWAGE
KW  - MARINE
KW  - DEBRIS
KW  - ENTANGLEMENT
KW  - DREDGING
KW  - EUTROPHICATION
KW  - FISHING
KW  - IMPACTS
KW  - HUMAN DISTURBANCE
KW  - NOISE POLUUTION
KW  - ARCTIC
KW  - ANTARCTIC
KW  - MICROBES
KW  - PLANKTON
KW  - INVERTEBRATES
KW  - FISH
KW  - BIRDS
KW  - TURTLES
KW  - MAMMALS
KW  - MARSHES
KW  - MANGROVES
KW  - INTER-TIDAL
PY  - 2016
AB  - This review covers selected 2015 articles on the biological effects of pollutants and human physical disturbances on marine and estuarine plants, animals, ecosystems and habitats. The review, based largely on journal articles, covers field and laboratory measurement activities (bioaccumulation of contaminants, field assessment surveys, toxicity testing and biomarkers) as well as pollution issues of current interest including endocrine disrupters, emerging contaminants, wastewater discharges, dredging and disposal, etc. Special emphasis is placed on effects of oil spills and marine debris due largely to the 2010 Deepwater Horizon oil blowout in the Gulf of Mexico. Several topical areas reviewed in the past (ballast water and ocean acidification) were dropped this year. The focus of this review is on effects, not pollutant fate and transport. There is considerable overlap across subject areas (e.g.some bioaccumulation papers may be cited in other topical categories). Please use keyword searching of the text to locate related but distributed papers. Use this review only as a guide and please consult the original papers before citing them.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - BJU International
JA  - BJU Int
VL  - 118
IS  - S5
SN  - 9781444335897
UR  - https://doi.org/10.1111/bju.13694
DO  - doi:10.1111/bju.13694
SP  - 4
EP  - 30
PY  - 2016
ER  - 

TY  - JOUR
TI  - ABSTRACTS FOR THE 10TH WORLD CONGRESS ON PEDIATRIC DERMATOLOGY
JO  - Pediatric Dermatology
VL  - 21
IS  - 3
SN  - 9781444335897
UR  - https://doi.org/10.1111/j.0736-8046.2004.21332.x
DO  - doi:10.1111/j.0736-8046.2004.21332.x
SP  - 312
EP  - 425
PY  - 2004
ER  - 

TY  - JOUR
TI  - Oral Research Communications of the 22nd ECVIM-CA Congress
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 26
IS  - 6
SN  - 9781444335897
UR  - https://doi.org/10.1111/jvim.12000
DO  - doi:10.1111/jvim.12000
SP  - 1505
EP  - 1538
PY  - 2012
ER  - 

TY  - JOUR
TI  - ASBMR 27th Annual Meeting M001–M525
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 20
IS  - S1
SN  - 9781444335897
UR  - https://doi.org/10.1002/jbmr.5650201306
DO  - doi:10.1002/jbmr.5650201306
SP  - S313
EP  - S437
PY  - 2005
ER  - 

TY  - JOUR
TI  - CONCURRENT SESSIONS: SUBMITTED ABSTRACTS
JO  - HPB
VL  - 13
IS  - s3
SN  - 9781444335897
UR  - https://doi.org/10.1111/j.1477-2574.2011.00383.x
DO  - doi:10.1111/j.1477-2574.2011.00383.x
SP  - 65
EP  - 159
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 48
IS  - S36
SN  - 9781444335897
UR  - https://doi.org/10.1002/ppul.22898
DO  - doi:10.1002/ppul.22898
SP  - 207
EP  - 453
PY  - 2013
ER  - 

AU  - Hol, W. G. J.
AU  - Verlinde, C. L. M. J.
C7  - pp. 10-25
TI  - Macromolecular crystallography and medicine
SN  - 9781119362296
UR  - https://doi.org/10.1107/97809553602060000656
DO  - doi:10.1107/97809553602060000656
SP  - 10-25
KW  - bacterial diseases
KW  - blindness
KW  - cancers
KW  - cardiovascular disorders
KW  - diabetes
KW  - drug design
KW  - drug metabolism
KW  - drug resistance
KW  - fungi
KW  - genetic diseases
KW  - helminths
KW  - infectious diseases
KW  - medicine and crystallography
KW  - neurological disorders
KW  - protozoan infections
KW  - structure-based drug design
KW  - vaccines
KW  - viruses
PY  - 2013
AB  - Abstract Macromolecular crystallography is discussed in terms of its impact on medicine, and selected examples of protein structures of medical relevance are provided. The application of crystallography to the study of genetic diseases is covered, as well as the role of crystallography in the development of novel pharmaceuticals.
ER  - 
